Terns Pharmaceuticals
TERN
TERN
93 hedge funds and large institutions have $310M invested in Terns Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 38 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
39% less capital invested
Capital invested by funds: $505M → $310M (-$195M)
50% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 20
83% less funds holding in top 10
Funds holding in top 10: 6 → 1 (-5)
Holders
93
Holding in Top 10
1
Calls
$2.17M
Puts
$84K
Top Buyers
| 1 | +$24.7M | |
| 2 | +$5.41M | |
| 3 | +$5.02M | |
| 4 |
Morgan Stanley
New York
|
+$4.32M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$3.34M |
Top Sellers
| 1 | -$16.6M | |
| 2 | -$9.72M | |
| 3 | -$5.11M | |
| 4 |
Millennium Management
New York
|
-$3.36M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$3.12M |